Ultragenyx Stock Analysis

RARE Stock  USD 46.69  0.13  0.28%   
Ultragenyx is undervalued with Real Value of 56.04 and Target Price of 90.56. The main objective of Ultragenyx stock analysis is to determine its intrinsic value, which is an estimate of what Ultragenyx is worth, separate from its market price. There are two main types of Ultragenyx's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Ultragenyx's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Ultragenyx's stock to identify patterns and trends that may indicate its future price movements.
The Ultragenyx stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Ultragenyx is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Ultragenyx Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Ultragenyx's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ultragenyx. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.

Ultragenyx Stock Analysis Notes

About 96.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 8.25. Ultragenyx had not issued any dividends in recent years. The entity had 1:3 split on the 17th of January 2014. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Ultragenyx Pharmaceutical Inc. was incorporated in 2010 and is headquartered in Novato, California. Ultragenyx Pharmaceu operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1119 people. To find out more about Ultragenyx contact Emil Kakkis at 415 483 8800 or learn more at https://www.ultragenyx.com.

Ultragenyx Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Ultragenyx's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Ultragenyx or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Ultragenyx generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 434.25 M. Net Loss for the year was (606.64 M) with loss before overhead, payroll, taxes, and interest of (370.78 M).
Ultragenyx currently holds about 542.8 M in cash with (474.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.75.
Over 96.0% of the company shares are owned by institutional investors
Latest headline from kalkinemedia.com: Wilsons Disease Market Size to Surge at Considerable Rate by 2032, Predicts DelveInsight

Ultragenyx Upcoming and Recent Events

Earnings reports are used by Ultragenyx to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Ultragenyx previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
15th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Ultragenyx Largest EPS Surprises

Earnings surprises can significantly impact Ultragenyx's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2015-05-11
2015-03-31-0.54-0.63-0.0916 
2020-10-27
2020-09-30-1.26-1.130.1310 
2015-11-09
2015-09-30-0.87-1.03-0.1618 
View All Earnings Estimates

Ultragenyx Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Ultragenyx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ultragenyx backward and forwards among themselves. Ultragenyx's institutional investor refers to the entity that pools money to purchase Ultragenyx's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Rock Springs Capital Management Lp2023-12-31
1.8 M
Alliancebernstein L.p.2023-12-31
1.6 M
Marshall Wace Asset Management Ltd2023-12-31
1.5 M
Baker Bros Advisors Lp2023-12-31
1.5 M
Geode Capital Management, Llc2023-12-31
1.3 M
Deutsche Bank Ag2023-12-31
1.2 M
First Trust Advisors L.p.2023-12-31
1.2 M
Adage Capital Partners Gp Llc2023-12-31
M
Pictet Asset Manangement Sa2023-12-31
M
Vanguard Group Inc2023-12-31
8.7 M
Rtw Investments, Llc2023-12-31
6.9 M
Note, although Ultragenyx's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ultragenyx Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.74 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ultragenyx's market, we take the total number of its shares issued and multiply it by Ultragenyx's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Ultragenyx Profitablity

Ultragenyx's profitability indicators refer to fundamental financial ratios that showcase Ultragenyx's ability to generate income relative to its revenue or operating costs. If, let's say, Ultragenyx is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Ultragenyx's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Ultragenyx's profitability requires more research than a typical breakdown of Ultragenyx's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.4) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.96) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.96.
Last ReportedProjected for 2024
Return On Capital Employed(0.47)(0.49)
Return On Assets(0.41)(0.43)
Return On Equity(2.20)(2.09)

Management Efficiency

Ultragenyx has return on total asset (ROA) of (0.2343) % which means that it has lost $0.2343 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.9323) %, meaning that it created substantial loss on money invested by shareholders. Ultragenyx's management efficiency ratios could be used to measure how well Ultragenyx manages its routine affairs as well as how well it operates its assets and liabilities. As of March 28, 2024, Return On Capital Employed is expected to decline to -0.49. In addition to that, Return On Assets is expected to decline to -0.43. At present, Ultragenyx's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 20.3 M, whereas Other Current Assets are projected to grow to (738.3 M).
Last ReportedProjected for 2024
Price Book Value Ratio 12.77  16.58 
Enterprise Value Multiple(6.47)(6.80)
Price Fair Value 12.77  16.58 
The analysis of Ultragenyx's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Ultragenyx's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Ultragenyx Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
0.662

Technical Drivers

As of the 28th of March, Ultragenyx has the Semi Deviation of 2.14, coefficient of variation of 7570.86, and Risk Adjusted Performance of 0.0151. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Ultragenyx, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Ultragenyx, which can be compared to its competition. Please validate Ultragenyx jensen alpha, potential upside, as well as the relationship between the Potential Upside and skewness to decide if Ultragenyx is priced more or less accurately, providing market reflects its prevalent price of 46.69 per share. Given that Ultragenyx has jensen alpha of 0.031, we advise you to double-check Ultragenyx's current market performance to make sure the company can sustain itself at a future point.

Ultragenyx Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Ultragenyx middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Ultragenyx. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Ultragenyx Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ultragenyx insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ultragenyx's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ultragenyx insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Ultragenyx Predictive Daily Indicators

Ultragenyx intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ultragenyx stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Ultragenyx Corporate Filings

F4
12th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
11th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
5th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10K
21st of February 2024
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
8K
15th of February 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
14th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
13th of February 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
13A
8th of February 2024
An amended filing to the original Schedule 13G
ViewVerify

Ultragenyx Forecast Models

Ultragenyx's time-series forecasting models are one of many Ultragenyx's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ultragenyx's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Ultragenyx Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ultragenyx prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ultragenyx shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ultragenyx. By using and applying Ultragenyx Stock analysis, traders can create a robust methodology for identifying Ultragenyx entry and exit points for their positions.
Last ReportedProjected for 2024
Pretax Profit Margin(1.40)(1.47)
Operating Profit Margin(1.31)(1.38)
Net Loss(1.40)(1.47)
Gross Profit Margin 0.90  1.05 

Current Ultragenyx Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ultragenyx analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ultragenyx analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
90.56Strong Buy20Odds
Ultragenyx current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Ultragenyx analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Ultragenyx stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Ultragenyx, talking to its executives and customers, or listening to Ultragenyx conference calls.
Ultragenyx Analyst Advice Details

Ultragenyx Stock Analysis Indicators

Ultragenyx stock analysis indicators help investors evaluate how Ultragenyx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ultragenyx shares will generate the highest return on investment. By understating and applying Ultragenyx stock analysis, traders can identify Ultragenyx position entry and exit signals to maximize returns.
Begin Period Cash Flow133.8 M
Common Stock Shares Outstanding73.5 M
Total Stockholder Equity275.4 M
Tax Provision-1.8 M
Property Plant And Equipment Net290.6 M
Cash And Short Term Investments777.1 M
Cash213.6 M
Accounts Payable42.1 M
Net Debt-170.4 M
50 Day M A47.1192
Total Current Liabilities280.4 M
Other Operating ExpensesB
Non Current Assets Total758.8 M
Non Currrent Assets Other51.7 M
Stock Based Compensation135.2 M
When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ultragenyx. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Complementary Tools for Ultragenyx Stock analysis

When running Ultragenyx's price analysis, check to measure Ultragenyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultragenyx is operating at the current time. Most of Ultragenyx's value examination focuses on studying past and present price action to predict the probability of Ultragenyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultragenyx's price. Additionally, you may evaluate how the addition of Ultragenyx to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Is Ultragenyx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultragenyx. If investors know Ultragenyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultragenyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.25)
Revenue Per Share
5.905
Quarterly Revenue Growth
0.233
Return On Assets
(0.23)
Return On Equity
(1.93)
The market value of Ultragenyx is measured differently than its book value, which is the value of Ultragenyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ultragenyx's value that differs from its market value or its book value, called intrinsic value, which is Ultragenyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultragenyx's market value can be influenced by many factors that don't directly affect Ultragenyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultragenyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultragenyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultragenyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.